Real-life persistence of golimumab in patients with chronic inflammatory rheumatic diseases: results of the 2-year observational GO-PRACTICE study

Authors:

Abstract
Full Papers; Authors: R.-M. Flipo, F. Tubach, P. Goupille, E. Lespessailles, N. Harid, S. Sequeira, P. Bertin, B. Fautrel